|
Stomach (Gastric) Cancer, Childhood
|
|
|
Stomach (Gastric) Cancer, Childhood Clinical Trials
- High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer
ClinicalTrials.gov Identifier: NCT00002722 - Active, not recruiting
childhood gastrointestinal cancer; stage III gastric cancer; stage IV gastric cancer
- Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
ClinicalTrials.gov Identifier: NCT00004099 - Active, not recruiting
stage II gastric cancer; stage III gastric cancer; stage IV gastric cancer; intestinal adenocarcinoma of the stomach; ...
- Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer
ClinicalTrials.gov Identifier: NCT00103324 - Active, not recruiting
recurrent gastric cancer; stage III gastric cancer; stage IV gastric cancer; diffuse adenocarcinoma of the stomach; ...
- Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer
ClinicalTrials.gov Identifier: NCT00002783 - Active, not recruiting
stage III gastric cancer; stage II gastric cancer; stage IV gastric cancer; adenocarcinoma of the stomach
- Antineoplaston Therapy in Treating Patients With Stomach Cancer
ClinicalTrials.gov Identifier: NCT00003524 - Active, not recruiting
stage III gastric cancer; stage IV gastric cancer; recurrent gastric cancer; adenocarcinoma of the stomach
- Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
ClinicalTrials.gov Identifier: NCT00074009 - Active, not recruiting
recurrent gastric cancer; stage III gastric cancer; stage IV gastric cancer; adenocarcinoma of the stomach
- Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer
ClinicalTrials.gov Identifier: NCT00103103 - Active, not recruiting
recurrent gastric cancer; stage IV gastric cancer; adenocarcinoma of the stomach
- Neoadjuvant Irinotecan and Cisplatin Followed By Surgical Resection in Treating Patients With Locally Advanced Cancer of the Stomach or Gastroesophageal Junction
ClinicalTrials.gov Identifier: NCT00062374 - Active, not recruiting
adenocarcinoma of the stomach; stage II gastric cancer; stage III gastric cancer; stage IV gastric cancer
- Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach
ClinicalTrials.gov Identifier: NCT00061932 - Recruiting
adenocarcinoma of the stomach; recurrent gastric cancer; stage III gastric cancer; stage IV gastric cancer
- Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach
ClinicalTrials.gov Identifier: NCT00075465 - Active, not recruiting
adenocarcinoma of the stomach; stage III gastric cancer; stage IV gastric cancer
- Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
ClinicalTrials.gov Identifier: NCT00084604 - Active, not recruiting
stage III gastric cancer; stage IV gastric cancer; recurrent gastric cancer; adenocarcinoma of the stomach
- S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery For Locally Advanced Stomach Cancer
ClinicalTrials.gov Identifier: NCT00134095 - Recruiting
adenocarcinoma of the stomach; stage II gastric cancer; stage III gastric cancer; stage IV gastric cancer
- Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
ClinicalTrials.gov Identifier: NCT00002615 - Active, not recruiting
stage II gastric cancer; stage III gastric cancer; adenocarcinoma of the stomach
- Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer
ClinicalTrials.gov Identifier: NCT00003298 - Active, not recruiting
stage III gastric cancer; stage IV gastric cancer; stage II gastric cancer; adenocarcinoma of the stomach
- S-1 and Cisplatin or Fluorouracil and Cisplatin in Treating Patients With Locally Advanced or Metastatic Gastric Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00128609 - Recruiting
stage IV gastric cancer; recurrent gastric cancer; adenocarcinoma of the stomach
- Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer
ClinicalTrials.gov Identifier: NCT00004873 - Active, not recruiting
stage III gastric cancer; stage IV gastric cancer; recurrent gastric cancer
- Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction
ClinicalTrials.gov Identifier: NCT00054457 - Active, not recruiting
adenocarcinoma of the stomach; Adenocarcinoma of the Esophagus; stage IV gastric cancer; recurrent gastric cancer; stage IV esophageal cancer; ...
- Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer
ClinicalTrials.gov Identifier: NCT00006038 - Active, not recruiting
stage III gastric cancer; stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage II gastric cancer; stage IV gastric cancer; ...
- Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer
ClinicalTrials.gov Identifier: NCT00004103 - Active, not recruiting
stage I gastric cancer; stage II gastric cancer; stage III gastric cancer; stage IV gastric cancer
- Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery
ClinicalTrials.gov Identifier: NCT00005876 - Active, not recruiting
stage III gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; ...
- Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus
ClinicalTrials.gov Identifier: NCT00005607 - Active, not recruiting
stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; ...
- Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach
ClinicalTrials.gov Identifier: NCT00020761 - Active, not recruiting
stage IV gastric cancer; recurrent gastric cancer; stage IV esophageal cancer; recurrent esophageal cancer; adenocarcinoma of the stomach; ...
- Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer
ClinicalTrials.gov Identifier: NCT00004236 - Active, not recruiting
stage III gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; ...
- Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus
ClinicalTrials.gov Identifier: NCT00002883 - Active, not recruiting
stage I gastric cancer; stage II gastric cancer; stage I esophageal cancer; stage II esophageal cancer; adenocarcinoma of the stomach; ...
- Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00020787 - Active, not recruiting
stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; ...
- Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer
ClinicalTrials.gov Identifier: NCT00006389 - Active, not recruiting
stage III gastric cancer; stage IV gastric cancer
- Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus
ClinicalTrials.gov Identifier: NCT00012363 - Active, not recruiting
stage IV gastric cancer; recurrent gastric cancer; stage IV esophageal cancer; recurrent esophageal cancer; adenocarcinoma of the stomach; ...
- Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer
ClinicalTrials.gov Identifier: NCT00006081 - Active, not recruiting
stage III gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; stage IV gastric cancer; ...
- BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy
ClinicalTrials.gov Identifier: NCT00017043 - Active, not recruiting
stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; ...
- Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach
ClinicalTrials.gov Identifier: NCT00003237 - Active, not recruiting
stage III gastric cancer; stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage II gastric cancer; stage II esophageal cancer; ...
- Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer
ClinicalTrials.gov Identifier: NCT00005060 - Active, not recruiting
stage II gastric cancer; stage III gastric cancer
- Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer
ClinicalTrials.gov Identifier: NCT00003862 - Completed
stage I gastric cancer; stage II gastric cancer; stage III gastric cancer; stage IV gastric cancer; adenocarcinoma of the stomach
- Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and GEJ
ClinicalTrials.gov Identifier: NCT00525785 - Recruiting
Stomach Cancer; Gastric Cancer
- Imatinib Mesylate in Treating Patients With Refractory Metastatic and/or Unresectable Stomach or Gastroesophageal Junction Cancer
ClinicalTrials.gov Identifier: NCT00068380 - Active, not recruiting
recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; stage IV esophageal cancer; stage III esophageal cancer; ...
- S-1 and Cisplatin Before Surgery in Treating Patients With Stage IV Gastric Cancer
ClinicalTrials.gov Identifier: NCT00088816 - Recruiting
stage IV gastric cancer; adenocarcinoma of the stomach
- Irinotecan in Treating Patients With Esophageal or Stomach Cancer
ClinicalTrials.gov Identifier: NCT00003748 - Active, not recruiting
stage III gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; stage II gastric cancer; ...
- Omeprazole and Amoxicillin and/or Vitamin and Mineral Supplements and/or Garlic Supplements in Preventing Stomach Cancer in Patients With Precancerous Stomach Lesions
ClinicalTrials.gov Identifier: NCT00134121 - Active, not recruiting
Gastric Cancer; Precancerous Condition
- Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer
ClinicalTrials.gov Identifier: NCT00040859 - Active, not recruiting
Esophageal Cancer; Gastric Cancer
- Chlorambucil Compared With No Further Therapy Following Anti- Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach
ClinicalTrials.gov Identifier: NCT00003617 - Active, not recruiting
stage I gastric cancer
- Oblimersen, Cisplatin, and Fluorouracil in Treating Patients With Advanced Esophageal, Gastroesophageal Junction, or Stomach Cancer
ClinicalTrials.gov Identifier: NCT00064259 - Active, not recruiting
Esophageal Cancer; Gastric Cancer
- Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer
ClinicalTrials.gov Identifier: NCT00003172 - Completed
stage III gastric cancer; recurrent gastric cancer; stage IV gastric cancer
- An International Phase 2 Study Of Su011248 In Patients With Advanced / Metastatic Gastric Cancer Failing Chemotherapy
ClinicalTrials.gov Identifier: NCT00226811 - Recruiting
Stomach Cancer
- Irofulven in Treating Patients With Recurrent or Metastatic Gastric Cancer
ClinicalTrials.gov Identifier: NCT00062257 - Completed
recurrent gastric cancer; stage IV gastric cancer; adenocarcinoma of the stomach
- ILF With/Without Cisplatin for Advanced Gastric Cancer
ClinicalTrials.gov Identifier: NCT00320294 - Active, not recruiting
Stomach Neoplasm
- LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer
ClinicalTrials.gov Identifier: NCT00010270 - Active, not recruiting
Colorectal Cancer; Esophageal Cancer; Gastric Cancer; Pancreatic Cancer
- Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
ClinicalTrials.gov Identifier: NCT00022139 - Active, not recruiting
stage III gastric cancer; stage II esophageal cancer; stage III esophageal cancer; adenocarcinoma of the stomach; ...
- DX-8951f in Treating Patients With Metastatic Stomach Cancer
ClinicalTrials.gov Identifier: NCT00017212 - Completed
stage III gastric cancer; stage IV gastric cancer; recurrent gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; ...
- A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer
ClinicalTrials.gov Identifier: NCT00123318 - Active, not recruiting
Gastric Cancer
- Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach
ClinicalTrials.gov Identifier: NCT00004233 - Active, not recruiting
Gastric Cancer; Esophageal Cancer; Adenocarcinoma of the Esophagus
- Chemoprevention of Gastric Cancer by Intervention With Helicobacter Pylori and Cyclooxygenase Pathway
ClinicalTrials.gov Identifier: NCT00498134 - Active, not recruiting
Stomach Neoplasms
- Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00052910 - Recruiting
Esophageal Cancer; Gastric Cancer
- Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer
ClinicalTrials.gov Identifier: NCT00524186 - Recruiting
Esophageal Cancer; Gastric Cancer
- Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer
ClinicalTrials.gov Identifier: NCT00201747 - Active, not recruiting
Esophageal Cancer; Esophagus Cancer; Cancer of Stomach; Stomach Cancer
- Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer
ClinicalTrials.gov Identifier: NCT00514020 - Recruiting
Gastric Cancer
- Docetaxel and Oxaliplatin in Gastric Cancer
ClinicalTrials.gov Identifier: NCT00382720 - Recruiting
Stomach Neoplasms
- Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors
ClinicalTrials.gov Identifier: NCT00511576 - Recruiting
Breast Cancer; Lung Cancer; Pulmonary Cancer; Non-Small-Cell Lung Carcinoma; Prostate Cancer; Prostatic Cancer; Gastric Cancer; Stomach Cancer
- Metastatic Gastric Cancer FFCD 03-07
ClinicalTrials.gov Identifier: NCT00374036 - Recruiting
Stomach Cancer; Neoplasm Metastasis
- Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer
ClinicalTrials.gov Identifier: NCT00217581 - Recruiting
Esophageal Cancer; Gastric Cancer
- S-1 and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage III Stomach Cancer
ClinicalTrials.gov Identifier: NCT00182611 - Recruiting
Gastric Cancer
- Trial of Adjuvant Chemotherapy for Gastric Cancer
ClinicalTrials.gov Identifier: NCT00296322 - Recruiting
Stomach Cancer
- Trial of Adjuvant Chemotherapy for Gastric Cancer
ClinicalTrials.gov Identifier: NCT00296335 - Recruiting
Stomach Cancer
- Study of Adjuvant Radiochemotherapy for Gastric Cancer
ClinicalTrials.gov Identifier: NCT00188266 - Recruiting
Stomach Neoplasms
- Docetaxel and Epirubicin in Advanced Gastric Cancer
ClinicalTrials.gov Identifier: NCT00375999 - Recruiting
Stomach Neoplasms
- Safety and Efficacy of G17DT Immunogen in the Treatment of Gastric and Gastroesophageal Cancer
ClinicalTrials.gov Identifier: NCT00042510 - Active, not recruiting
Stomach Neoplasms; Esophageal Neoplasms
- Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas
ClinicalTrials.gov Identifier: NCT00012181 - Active, not recruiting
childhood bone cancer; childhood brain cancer; childhood eye cancer; childhood kidney tumors; childhood non-Hodgkin's lymphoma; ...
- Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stomach Cancer That Can Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00335959 - Recruiting
Gastric Cancer
- Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Stomach Cancer
ClinicalTrials.gov Identifier: NCT00354224 - Recruiting
Gastric Cancer
- Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)
ClinicalTrials.gov Identifier: NCT00152217 - Active, not recruiting
Gastric Cancer
- Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer
ClinicalTrials.gov Identifier: NCT00032123 - Completed
stage IV gastric cancer; stage IV esophageal cancer; adenocarcinoma of the stomach; Adenocarcinoma of the Esophagus; recurrent esophageal cancer; ...
- Irinotecan in Treating Patients With Advanced Cancer of the Stomach
ClinicalTrials.gov Identifier: NCT00003137 - Completed
stage IV gastric cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; intestinal adenocarcinoma of the stomach; ...
- Perioperative Chemoradiotherapy for Potentially Resectable Gastric Cancer
ClinicalTrials.gov Identifier: NCT00420394 - Recruiting
Stomach Neoplasms
- Docetaxel, Oxaliplatin and S-1 (DOS) for Advanced Gastric Cancer
ClinicalTrials.gov Identifier: NCT00525005 - Recruiting
Stomach Neoplasms
- Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Metastatic or Inoperable Locally Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (Cancer)
ClinicalTrials.gov Identifier: NCT00084617 - Active, not recruiting
Esophageal Cancer; Gastric Cancer
- Study of Cetuximab Plus P-HDFL for the First-Line Treatment of Advanced Gastric Cancer
ClinicalTrials.gov Identifier: NCT00384878 - Recruiting
Stomach Neoplasms
- Efficacy and Safety of Sunitinib in Metastatic Gastric Cancer
ClinicalTrials.gov Identifier: NCT00411151 - Recruiting
Adenocarcinoma of Stomach; Barret Esophagus
- Bi-Weekly Docetaxel Plus 24-Hour Infusion of HDFL and for Inoperable Advanced or Metastatic Gastric Cancer
ClinicalTrials.gov Identifier: NCT00155883 - Recruiting
Gastric Cancer
- Cetuximab in Treating Patients With Ménétrier Disease at High Risk of Developing Stomach Cancer
ClinicalTrials.gov Identifier: NCT00477880 - Recruiting
Gastric Cancer; Precancerous/Nonmalignant Condition
- Identifying Genetic Markers for Esophageal Cancer and Stomach Cancer in Chinese Populations
ClinicalTrials.gov Identifier: NCT00558415 - Recruiting
Esophageal Cancer; Gastric Cancer
- Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus
ClinicalTrials.gov Identifier: NCT00003192 - Completed
recurrent gastric cancer; stage III gastric cancer; stage IV gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; ...
- Trial of Docetaxel, Oxaliplatin and Capecitabine (TEX) in Advanced or Metastatic Gastric Cancer
ClinicalTrials.gov Identifier: NCT00511446 - Recruiting
Stomach Neoplasms
- Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
ClinicalTrials.gov Identifier: NCT00394433 - Recruiting
Esophageal Cancer; Stomach Cancer
- Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer
ClinicalTrials.gov Identifier: NCT00004257 - Completed
stage III gastric cancer; stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage II gastric cancer; stage I gastric cancer; ...
- Optical Coherence Tomography of the Gastrointestinal Tract
ClinicalTrials.gov Identifier: NCT00579748 - Active, not recruiting
Barrett's Esophagus With or Without Dysplasia; Patients With Early Esophageal or Gastric Cancer; Patients With Intestinal Metaplasia of the Stomach
- A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric Cancer
ClinicalTrials.gov Identifier: NCT00512681 - Recruiting
Stomach Neoplasms
- Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection
ClinicalTrials.gov Identifier: NCT00464893 - Recruiting
Gastric Cancer; Gastric Adenocarcinoma
- FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer
ClinicalTrials.gov Identifier: NCT00098527 - Suspended
adenocarcinoma of the stomach; recurrent gastric cancer; Adenocarcinoma of the Esophagus; recurrent esophageal cancer
- A Double-Blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium
ClinicalTrials.gov Identifier: NCT00125736 - Recruiting
Stomach Ulcer
- Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder
ClinicalTrials.gov Identifier: NCT00489515 - Recruiting
Colorectal Cancer; Gallbladder Cancer; Gastric Cancer; Pancreatic Cancer; Small Intestine Cancer
- Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Previously Untreated Stomach Cancer or Gastroesophageal Junction Cancer That Can Be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00450203 - Not yet recruiting
Gastric Cancer
- Study of Sunitinib With S-1 and Cisplatin for Gastric Cancer
ClinicalTrials.gov Identifier: NCT00553696 - Not yet recruiting
Stomach Neoplasms
- An Effective and Well-Tolerated Regimen of Docetaxel Plus High-Dose 5-Fluorouracil and Leucovorin(HDFL)to Treat Inoperable Advanced or Metastatic Gastric Cancer
ClinicalTrials.gov Identifier: NCT00270543 - Not yet recruiting
Stomach Neoplasms
- Avastin and Taxotere for Esophagogastric Cancer
ClinicalTrials.gov Identifier: NCT00137813 - Active, not recruiting
Esophageal Cancer; Gastric Cancer
- Intraperitoneal Floxuridine in Gastric Carcinoma
ClinicalTrials.gov Identifier: NCT00058916 - Recruiting
Stomach Neoplasms
- MATRIX EG (Matuzumab Treatment With ECX in Esophago-Gastric Cancer)
ClinicalTrials.gov Identifier: NCT00215644 - Active, not recruiting
Esophageal Cancer; Gastric Cancer
- Study of S-1 Versus Capecitabine as First-Line Chemotherapy in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric Cancer
ClinicalTrials.gov Identifier: NCT00580359 - Recruiting
Stomach Neoplasms
- A Phase III Trial of Laparoscopy-Assisted Distal Gastrectomy in Early Gastric Cancer
ClinicalTrials.gov Identifier: NCT00546468 - Active, not recruiting
Gastric Cancer
- Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer
ClinicalTrials.gov Identifier: NCT00003994 - Active, not recruiting
stage I childhood liver cancer; recurrent childhood liver cancer; childhood hepatoblastoma
- BMS-247550 in Treating Patients With Recurrent Metastatic Stomach Cancer That Has Been Previously Treated With Chemotherapy
ClinicalTrials.gov Identifier: NCT00017056 - Completed
stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; ...
- Biological Therapy in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00005956 - Active, not recruiting
stage III gastric cancer; stage IIIB breast cancer; stage II gastric cancer; stage IIIA breast cancer; stage III ovarian epithelial cancer; ...
- Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
ClinicalTrials.gov Identifier: NCT00003157 - Completed
recurrent gastric cancer; recurrent pancreatic cancer; stage IV gastric cancer; stage IVA pancreatic cancer
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
